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block for rhinoscopy with nasal biopsy of dogs
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A maxillary nerve block via a modified infraorbital approach, applied before
rhinoscopy and nasal biopsy, would decrease nociception, minimize cardiorespiratory
anesthetic effects, and improve recoveries. In a crossover study, bupivacaine or
equivalent volume of saline was administered to 8 healthy dogs via a modified
infraorbital approach into each pterygopalatine region. Rhinoscopy and nasal biopsy were
performed. Heart rate, blood pressure, plasma cortisol and norepinephrine concentrations,
purposeful movement, and pain scores were monitored. Following a 14-day washout,
dogs received the alternate treatment on the contralateral side. Blood pressures were
significantly higher for the saline treatment than bupivacaine treatment. Plasma cortisol
concentrations in the saline treatment were significantly higher 5 minutes after biopsy
than at biopsy. No other parameters were significant. Using a maxillary nerve block via a
modified infraorbital approach prior to rhinoscopy and nasal biopsy reduced procedural
nociception. These findings warrant further evaluation in dogs with nasal disease.
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INTRODUCTION
Nasal diseases are common in small animal patients, and rhinoscopy with nasal
biopsy has become the gold standard procedure for evaluation and diagnosis of nasal
diseases in the dog.1,2 Unlike human patients, our animal patients require general
anesthesia for endoscopic procedures, carrying with that, potential risks associated with
an anesthetic event.3 Multimodal anesthesia, incorporating the use of many different
treatment modalities, provides the safest anesthesia and has become the gold standard for
anesthetizing patients with greater risk for anesthetic complications.4 Careful study of the
innervation of the face and nose in the dog and human has provided insight into the use
of regional nerve blocks and local anesthetics to desensitize the nasal cavity. This may
provide benefit to the patient with long lasting effects, minimizing the anesthetic
complications, and providing a better recovery following rhinoscopy with nasal biopsy or
other painful invasive procedures.
Rhinoscopy with nasal biopsy
Canine nasal diseases, which include a variety of inflammatory, infectious, and
neoplastic processes, are a common cause for sneezing and nasal discharge in the dog.2
Differentiating between the multiple disease etiologies is paramount, as the treatment for
each disease process is different and often tailored. Historically, many nasal disease
processes would require an invasive surgical technique in order to obtain the diagnosis or
1

the use of non-invasive techniques with a low diagnostic yield.5 The use of endoscopy to
visualize areas of the nose that are not available to the naked eye have made procedures
in human and animal medicine less challenging over the past several decades.5
Rhinoscopy involves the use of a rigid fiber optic camera to visualize the contents of the
nasal cavity via the nares, and a flexible fiber optic camera to visualize the caudal
nasopharynx via the mouth by retroflexing the camera around the caudal aspect of the
soft palate dorsally.6 With new technology comes new concerns. Rhinoscopy is a very
stimulating procedure to the internal structures of the nose and often causes patients to
develop a sudden light plane of anesthesia, with accompanying head shaking, gagging,
swallowing, sneezing, and chewing. The nasal mucosa is very sensitive to touch, and
introduction of the scoping equipment into the nasal cavity can cause sudden stimulation
and patient movement. Since our animal patients require general anesthesia for
endoscopic evaluations, these patients must be kept at a deeper anesthetic plane to
prevent movement, thus minimizing the risk of trauma and injury to the patient, and
damage to expensive endoscopy equipment. Associated with a deeper plane of anesthesia
is a greater likelihood of cardiorespiratory complications such as apnea and hypotension.7
Anesthesia
With any general anesthetic event, there are inherent risks associated, especially
in patients with underlying disease processes.8-10 Recent literature on anesthetic mortality
in dogs was measured at 0.17%, with 0.05% in healthy dogs, increasing to 1% in patients
with more severe systemic disease processes.11 The American Society of
Anesthesiologists (ASA) developed a classification system in humans which has been
adapted and widely accepted into veterinary medicine, categorizing patients based upon
2

their disease process and physical health status. In this system, patients with a higher
ASA classification have a greater risk of anesthetic associated death.12,13 Dogs
undergoing rhinoscopy with nasal biopsy procedure are often of a higher ASA
classification, as they are presenting with a disease process that requires rhinoscopy with
nasal biopsy, increasing the anesthetic risk to these patients as compared to a normal
healthy patient. Chronic and systemic disease processes increase the risks associated with
anesthesia, increasing complication rates seen during and perioperatively.11 Inhalant
anesthetics cause a dose-dependent cardiovascular depression, resulting in decreased
cardiac output and hypotension.14 To help make the anesthetic event for diagnostic
procedures the safest for the animal, multimodal or balanced techniques have been
adopted. These include many different treatment modalities offering many of the
benefits of drug combinations at lower doses, while limiting the side effects of a single
drug used at a high dose, to provide the anesthesia and analgesia required to perform an
invasive and painful diagnostic procedure in the veterinary patient.15,16 A variety of
different drugs and techniques can be included, such as opioids, injectable anesthetics, α2 adrenergic agonists, NMDA antagonists, NMBAs, and local anesthetics, in addition to
inhalant anesthesia.17 The value of balanced anesthesia has been studied extensively, and
its use has a significant additional benefit in the post-operative period.18 The control of
post-operative pain, better comfort of patients in recovery, and the ability to rest and heal
is paramount. This can be achieved by preventing pain via a multimodal analgesic
approach in the recovery period, decreasing the perioperative stress levels and allowing
the body to heal.4,19
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Stress response
A stress response occurs any time there is trauma or injury, and is associated with
anesthesia and surgery.20 Hormonal and metabolic changes take place in response to
these stressors. Increased corticotrophin release from the pituitary gland stimulates the
release of cortisol from the adrenal cortex, and activation of the autonomic sympathetic
nervous system by the hypothalamus increases release of norepinephrine from
presynaptic nerve terminals.21 In clinical patients, an increase in the sympathetic nervous
system response manifests as cardiovascular effects such as increased heart rate,
respiratory rate, and blood pressure, which can be caused by anxiety, trauma, pain, or a
nociceptive stimulus. In wild animals, stress responses have developed to allow injured
animals to survive without showing overt signs of illness.20
Plasma catecholamine concentrations can be a useful indicator of stress and
nociceptive stimulation occurring in human and veterinary patients.22 Following a
stressful event, plasma norepinephrine concentrations increase immediately, whereas
plasma cortisol concentrations can take up to 4-6 hours for increases to be seen.23,24 In
several surgical studies, catecholamine measurement was used as a definitive method to
determine effectiveness of analgesic and balanced anesthesia protocols, in comparison to
general post-operative comfort via a pain scoring questionnaire. In some orthopedic
patients, no differences in pain scoring was noted, though decreases in plasma cortisol
concentrations were seen.25 In pediatric patients, epidural anesthesia decreased the
catecholamine stress response more significantly that opioids alone.26 In dogs undergoing
repeated noxious stimuli, increased plasma cortisol levels correlated to increases in
surgical stress.27
4

Anatomy of the nose
The nasal cavity, which contains the primary sensory organ in the dog, is very
sensitive and contains an intricate network of nerves that would make rhinoscopy a
painful procedure in an awake animal. Rhinoscopy is also very stimulating in an
anesthetized animal, and makes for difficult analgesia in the dog. The nose is complex,
both in structure and function, providing olfaction, as well as humidifying, warming, and
filtering of inhaled air.28 Understanding the anatomy of the dog face and nose can provide
insight into the development and use of techniques allowing the use of regional nerve
blocks to anesthetize areas of the face and nose, providing antinociceptive properties for
painful and invasive diagnostic procedures.
Though there are many distinct differences between the human and canine facial
anatomy, there are many strong similarities.29 The cranial nerves serve many of the same
primary functions in the human and dog, as they do in all mammals, though the nasal
anatomy of the dog is more pronounced and of greater importance to the dog than the
human.30 One of the major differences in the human and dog nasal anatomy is that dogs
are macrosmats, using the nose for primarily olfaction, with higher levels of olfactory
function, while humans are microsmats, using the nose primarily for breathing.28,29,31
Dogs have much larger and complex turbinate structures with a greater olfactory area
than that of the human,32 though nerve anatomy and physiology, especially that of the
trigeminal nerve, remains much the same.33 Comparative anatomy of the man, dog, and
other species has shown that despite differences in appearance and function, the
developmental origin of the trigeminal nerve, and its function, has remained the same.34
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The trigeminal nerve
Cranial nerve V, the trigeminal nerve, is the largest of all the cranial nerves,
dividing into three branches providing motor, sensory, and autonomic innervation the
structures of the face. Though the trigeminal nerve itself does not provide autonomic
innervation, it does communicate and travel with autonomic fibers from the oculomotor
(cranial nerve III), facial (cranial nerve VII), and glossopharyngeal (cranial nerve IX)
nerves to collectively provide autonomic innervation to lacrimal, nasal, and salivary
glands.35-37 The trigeminal nerve exits the brainstem entering trigeminal canal, where the
sensory trigeminal ganglion resides. Distal to the trigeminal ganglion, the trigeminal
nerve separates into its three branches: the ophthalmic (V1), maxillary (V2), and
mandibular (V3) nerves, each providing a range of innervation to its associated areas of
the face (Figure 1.1).38
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Figure 1.1

The trigeminal nerve.

Illustration adapted from Dyce, Sack, and Wensing. Textbook of Veterinary Anatomy,
3rd edition. The ophthalmic nerve and its branches (V1, in blue). 1, ophthalmic n.; 2,
frontal n.; 3, lacrimal n.; 4, nasociliary n.; 4', infratrochlear n.; 4", long ciliary n. The
maxillary nerve and its branches (V2, in red). 5, maxillary n.; 6, infraorbital n.; 7,
zygomatic n.; 8, pterygopalatine n.; 9, lesser palatine n.; 10, greater palatine n.; 11, caudal
nasal n. The mandibular nerve and its branches (V3, in green). 12, mandibular n.; 13,
masticatory n.; 14, deep temporal n.; 15, buccal n.; 16, pterygoid n.; 17, auriculotemporal
n.; 18, lingual n.; 18', sublingual n.; 19, inferior alveolar n.; 19', mylohyoid n.; 19",
mental n.
The ophthalmic nerve (V1)
Distal to the trigeminal ganglion, the first branch of the trigeminal nerve, the
ophthalmic nerve, emerges from the cranial vault through the orbital fissure. The
branches of the ophthalmic nerve provide sensory innervation to the eyelids, eyeball,
nasal mucosa, and skin of the nose. The ophthalmic nerve divides three main branches,
the lacrimal, frontal, and nasociliary nerves. The lacrimal nerve innervates the skin of the
lateral canthus of the eye. The frontal nerve divides into the supraorbital and
supratrochlear nerves, innervating the cutaneous area on the lateral two-thirds of the
7

upper eyelid and continuing to dorsal midline, innervating the bone and mucosa of the
frontal sinus. The nasociliary nerve branches into the infratrochlear, ethmoidal, and long
ciliary nerves, providing innervation to the medial canthus of the eye and the frontal
sinus, the septum and wall of the nasal cavity, and the sensitive tissues of the eyeball,
cornea and bulbar conjunctiva, respectively.36,38
The lacrimal nerve associates with and carries the postganglionic parasympathetic
fibers of the facial nerve (from the pterygopalatine ganglion) to provide innervation to the
lacrimal gland.39 The nasociliary nerve communicates with the ciliary ganglion to form
the short ciliary branches of the oculomotor nerve with post ganglionic sympathetic fibers
from the cranial cervical ganglion supplying three smooth muscles groups in the orbit:
the third eyelid retractor, the smooth muscle bands pulling the eyeball rostrally, and the
pupil dilator.36,37
The maxillary nerve (V2)
The maxillary nerve exits the cranial vault through the round foramen, running
across the pterygopalatine fossa ventral to the orbit rostrally toward the infraorbital
foramen and branching into several different nerves that provide sensory innervation to
the lower eyelid, nasal mucosa, upper teeth, upper teeth, and nose. The maxillary nerve
has three main branches: the zygomatic, pterygopalatine, and infraorbital nerves. The
zygomatic nerve branches into the zygomaticofacial and zygomaticotemporal nerves,
innervating the lower eyelid, medial and lateral canthi of the eyes, and the cutaneous area
dorsal to the zygomatic arch cranial to the external ear. The pterygopalatine nerve then
branches into the greater palatine, lesser palatine, and caudal nasal nerves. The greater
palatine and lesser palatine nerves innervate the mucosa of the hard palate and floor of
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the nasal vestibule, and the soft palate, respectively. The caudal nasal nerve innervates
the nasal mucosa around the ventral meatus of the nasal cavity, maxillary sinus, and
palate. The infraorbital nerve branches into the caudal, middle, and rostral superior
alveolar branches innervating all of the maxillary teeth, the external and internal nasal
branches, and the superior labial branches, innervating the most rostral labial and nasal
surfaces of the nose and muzzle.33,36,38
The zygomaticotemporal nerve contains postganglionic parasympathetic fibers of
the facial nerve (from the pterygopalatine ganglion) that supply the lacrimal gland. The
lesser palatine nerve also contains postganglionic parasympathetic fibers (from the
geniculate ganglion) that supply visceral afferent fibers to the soft palate as well as taste
fibers, and the caudal nasal nerve contains postganglionic parasympathetic fibers (from
the pterygopalatine ganglion) that supply the nasal and palatine glands. The greater
palatine nerve also contains parasympathetic fibers supplying the palatine glands.36,37
The mandibular nerve (V3)
The mandibular nerve exits through the oval foramen, separating into many
branches providing both motor and sensory innervation to the buccal cavity, tongue,
lower teeth, lower lip, skin of portions the head, cheek, commissure of the mouth, ear,
and mucosa of intraosseous parts of the external ear. The branches providing motor
innervation to the muscles of mastication and are the masticator, masseteric, deep
temporal, and lateral and medial pterygoid nerves, innervating the masseter, temporalis,
and lateral and medial pterygoid muscles. The tensor tympani nerve provides motor
innervation to the tensor tympani muscle of the malleus and the tensor veli palatini nerve
provides motor to the thin muscle of the soft palate. The remaining mandibular nerve
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branches provide only sensory innervation to their respective areas of the face. The
buccal nerve innervates the tissues of the cheek. The auriculotemporal nerve innervates
the mandible, skin of the temporal region and external ear, and lining of the canal leading
to the tympanum. The transverse facial nerve innervates the skin at the commissure of the
lips. The lingual and sublingual nerves innervate the tongue and floor of the oral cavity.
The inferior alveolar, mylohyoid, and mental nerves innervate the mandibular teeth, the
mylohyoid muscle, and the lower lip and chin, respectively. The branches of the
mandibular nerve do not provide any innervation to the nasal cavity or structures of the
nose.36-38,40
The auriculotemporal and buccal nerves contains postganglionic parasympathetic
branches of the glossopharyngeal nerve (from the otic ganglion) innervating the parotid
salivary glands and buccal glands, respectively. The lingual nerve branches to the
superficial sublingual nerve that joins visceral efferent fibers of the facial nerve (from the
mandibular ganglion) to innervate the salivary glands, and gustatory fibers of taste buds
(from the geniculate ganglion of the facial nerve) of the rostral two-thirds of the
tongue.37,38
Regional anesthetic techniques
Regional nerve blocks have been performed for years, especially to provide
anesthesia for dental, mouth, and ocular procedures in human and animal patients.41-44 In
human patients, a greater emphasis has been on the use of regional anesthesia for many
areas of the face, including the eye, nose, and mouth, in order to complete painful
procedures without the need for general anesthesia and the associated risks.45 In our
animal patients, the use of regional nerve blocks can decrease the nociception, resulting
10

in the use of a lighter plane of anesthesia, more stable vital signs, smoother recoveries,
and earlier discharge from the hospital.46 Similar results were also seen with the use of
regional nerve blocks in human pediatric patients for maxillofacial surgeries, decreasing
the post-operative need for analgesics and respiratory complications,47 as well as
decreased post-operative stress response.48 Providing pre-emptive analgesia,49 especially
the use of local anesthetics in the form of regional nerve blocks, prior to inducing pain
associated with surgical trauma, is one of the modalities commonly sought for
multimodal anesthesia.
Maxillary nerve block studies
Blocking portions of the trigeminal nerve has been used for years to provide local
anesthesia for dental procedures in dogs, though Cremer et al.50 recently questioned if
blocking the maxillary and infraorbital nerve would be successful for nasal procedures
such as rhinoscopy in the dog. A percutaneous approach to the maxillary nerve51 and an
infraorbital nerve block using lidocaine was evaluated for anterior and posterior
rhinoscopy using a flexible endoscope. The results showed that the maxillary block
decreased the incidence of adverse reactions during posterior rhinoscopy, with more
stable cardiovascular parameters compared to the infraorbital block or a sham block.50
Viscasillas et. al. published a novel method to approach the maxillary nerve to
provide a safer technique for inexperienced anesthetists to block the maxillary nerve with
a greater success rate with staining of nerves, without increasing the incidence of
complications than the percutaneous technique. Providing anesthesia to the maxillary
nerve in the pterygopalatine fossa can block a portion of the sensory innervation from the
nasal cavity and provide patients with a safer anesthetic episode as well as several hours
11

of postoperative analgesia. In this cadaver study, it was found that complete staining of
the maxillary nerve via the infraorbital approach was greater than that seen via the
percutaneous approach, when performed by inexperienced anesthetists. The use of an
intravenous over-the-needle catheter may decrease the incidence of trauma to the nerves
or vasculature in the area of the infraorbital canal and pterygopalatine fossa. Though
there was no gross trauma to the vasculature or intravascular injection, this was evaluated
in cadaver dogs, making it difficult to compare to live dogs.52
A third method to anesthetize the maxillary nerve was studied by Langton et al.
using a transorbital approach to the maxillary nerve in the pterygopalatine fossa. This was
compared to the traditional percutaneous approach to the maxillary nerve, determining
that in cadaver dogs, there was a greater staining success rate with the transorbital
approach than the traditional percutaneous approach, both performed by the same
inexperienced anesthetists.53 Potential complications that could result from this technique
are trauma to the eye, increasing intraocular pressures, and a potentially fatal
oculocardiac reflex.54,55 This is a sudden vagal-induced bradycardia associated with
traction to the extraocular muscles or pressure on the globe. This occurs via the long and
short ciliary and ophthalmic nerves, through communication between the ciliary and
trigeminal ganglia, and the vagus nerve, with cardio-inhibitory fibers terminating in the
myocardium. The vagal stimuli result in negative inotropic and chronotropic effects on
the heart, manifesting as a sudden bradycardia.56 This reflex is abolished and resolves
with discontinued manipulation of the globe and anticholinergic therapy.57
Attempts can also be made to block the ophthalmic branch of the trigeminal
nerve, as is performed in human patients undergoing trigeminal ganglion blockade for
12

trigeminal neuralgia or other pain syndromes,35,44,58 and blocking the ethmoidal,
nasociliary, and infratrochlear nerves for outpatient nasal surgery.59 The anatomy of the
human skull allows for direct access to the trigeminal ganglion,44 which may be more
difficult in the canine patient population, with varying skull shapes.36 This procedure also
does not go without risk, as the trigeminal ganglion is within the skull, immediately
adjacent to the brainstem.35,37
The ophthalmic nerve alone cannot be blocked using any local anesthetic
technique. The ophthalmic nerve exits the skull within the periorbita, along with the optic
nerve and vasculature to the globe.37 To get regional anesthesia of the ophthalmic nerve
branches, a block technique penetrating into or adjacent to the orbital cone must be
performed, such as a retrobulbar, peribulbar, or Peterson block.60-62 Each of these
techniques have been associated with complications such as hemorrhage, puncture of the
globe, and trauma to the optic nerve.
With the information from these previous studies, the use of the infraorbital
approach to apply local anesthetics to the maxillary nerve and its branches may be of
benefit to patients undergoing rhinoscopy with nasal biopsy. It is understood that the
maxillary branch of the trigeminal nerve does not supply complete innervation to the
nasal cavity, it may be successful at blocking a portion of the nerve, while employing a
technique that can be successfully performed by inexperienced anesthetists without
additional complications.
Local anesthetics
Since the mid 1800’s, local anesthetics have been used, specifically cocaine, to
desensitize areas of the body, making the patient unaware of the painful medical
13

procedure being undertaken, and remaining unaware for several hours afterward while in
recovery. Cocaine was determined to be addictive and hallucinogenic, and great strides
were made to develop different compounds that are less toxic, yet provide the same local
anesthetic properties as cocaine. The first versions of non-cocaine local anesthetics had a
high potential for allergic reactions, and many different local anesthetics have been
synthetized since then leading to the development of the local anesthetic compounds used
today.63
Local anesthetics are a class of drugs that provides reversible motor and sensory
blockade by blocking generation and propagation of nerve impulses. The movement of
sodium into the cell through voltage-gated sodium channels is required for propagation of
an action potential, local anesthetics impede nerve conduction and nerve cell membrane
depolarization by blocking the influx of sodium ions through voltage-gated sodium
channels, and to a lesser extent, by blocking voltage-dependent potassium and calcium
channels.63-65 Local anesthetics exhibit a pattern of sensory and motor blockade that can
be seen clinically in patients, known as a ‘differential block’, causing first vasodilation,
then loss of temperature and sharp pain sensation, then light touch, and finally motor
blockade.66 To achieve complete sensory blockade, the local anesthetic must reach three
consecutive Nodes of Ranvier, known as the ‘critical length’ needed to disrupt nerve
impulse propagation.67,68 This requires that local anesthetics be injected into a specific
location that the sensory blockade is to be achieved, making the knowledgeable use of
local and regional anesthetic techniques of utmost importance.
The different local anesthetic agents used clinically are lipophilic molecules that
contain a benzene ring and amide group that are bound with either an amide or ester
14

linkage, and their effectiveness is reliant upon its lipophilicity and degree of protein
binding within the tissues. These properties alter the onset and duration of action of local
anesthetics, making different local anesthetic agents appropriate for the duration of local
anesthesia we aim to achieve. The most commonly used local anesthetic agents used in
veterinary medicine are lidocaine, bupivacaine, and mepivacaine. Each agent has its own
unique properties that make their use appropriate in various clinical situations.
Lidocaine
Lidocaine is a short-acting, amino-amide local anesthetic that is one of the most
commonly used in both human and veterinary medicine. The rapid onset time and
moderate toxicity makes lidocaine the most versatile local anesthetic used today.
Duration of anesthesia of lidocaine alone as an infiltrative block is about 1 hour, though
when combined with adjunct agents, its duration can be prolonged up to 3 hours or
longer.69 Lidocaine is also a Class Ib antiarrhythmic drug that can be given intravenously,
working by shortening the action potential duration and refractory period in normal
cardiac myocytes, and prevents ischemia-mediated shortening of ventricular
depolarization in damaged myocytes, making its use for ventricular arrhythmias its most
important pharmacologic activity.70 Lidocaine can decrease the requirements for inhalant
anesthetics needed as an intravenous component of multimodal anesthesia.15,71
Bupivacaine
Bupivacaine, a long-acting, amino-amide local anesthetic agent, commonly used
in veterinary medicine, has an onset time of 20-30 minutes, and may provide
desensitization for up to 10 hours following injection in the dog.72 It can be used for local
15

infiltrative techniques only, as the drug is highly cardiotoxic, and intravenous injection
can result in death. All local anesthetics have direct negative inotropic effects on the
heart,73 however, long-acting local anesthetics are more arrhythmogenic than shorteracting drugs, due to the duration of time required for unbinding from cardiac sodium
channels. In electrocardiographic and echocardiographic studies performed in the dog,
bupivacaine caused a sudden impaired ventricular systolic function followed by profound
right ventricular dilation following IV administration, with multiple ECG changes
including widening of the QRS complex, bradycardia, ventricular arrhythmias, and
electromechanical dissociation.74 These changes are likely due to the effect on sodium
and calcium channels, decreasing myocardial contractility.75,76 These properties become
exacerbated in the anesthetized animal, making the arrhythmogenic potential of
bupivacaine even greater at high doses, or with high plasma concentrations seen
following inadvertent intravenous administration.63,64
Even with the potential for significant cardiotoxicity in animal patients,
bupivacaine provides the longest duration of desensitization of all of the clinically used
local anesthetics today, and with careful use of bupivacaine given as an infiltrative
injection at therapeutic doses, bupivacaine is a great choice for long-term local anesthesia
in the dog.
Mepivacaine
Mepivacaine is another amino-amide local anesthetic that is pharmacologically
similar to lidocaine with a longer duration of effect up to 2 hours. Its main use in
veterinary medicine is for peripheral nerve blocks in horses, as it is the least neurotoxic of
all commonly used local anesthetics.77 Its use is not very common in small animal
16

medicine, as lidocaine and bupivacaine use has been more popular and more accepted for
local anesthetic techniques, as neurotoxicity and ataxia are less concerning in our small
animal patients.64
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EVALUATION OF A MODIFIED INFRAORBITAL APPROACH FOR A
MAXILLARY NERVE BLOCK FOR RHINOSCOPY WITH NASAL
BIOPSY OF DOGS
Introduction
Rhinoscopy with concurrent nasal biopsy is considered to be a core component
for investigation of nasal disease of dogs.1 To the authors’ knowledge, there is not a
simple and effective method that provides regional anesthesia to the nasal cavity for
rhinoscopy and biopsy. Sudden periods of arousal during rhinoscopy and nasal biopsy are
often observed clinically and can be associated with movements such as sneezing, head
shaking, and chewing. These movements have potential to cause injury to patients and
damage to expensive endoscopy equipment. To decrease the likelihood of movement,
rhinoscopy patients are often maintained at a deep plane of anesthesia, which causes
dose-dependent cardiorespiratory depression that can lead to hypotension and apnea.2–5
Use of multimodal anesthesia, including local anesthetics for a local or regional nerve
block, may help to decrease the amount of inhalation anesthetics required, thereby
decreasing the severity of complications associated with a deep plane of anesthesia.6–9
Providing regional antinociception to the nasal cavity and corresponding
structures is challenging because of the complexity of innervation to the face and nose.
Knowledge of the anatomy of these nerves is needed to safely and effectively provide
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regional antinociception. A comparison of percutaneous maxillary nerve blocks and
infraorbital nerve blocks in dogs undergoing rhinoscopy revealed that the maxillary nerve
block was superior to the infraorbital block for preventing adverse reactions during
rhinoscopy of the caudal portion of the nasopharynx.10 However, some authors believe
that the infraorbital approach is more successful than the percutaneous approach for
maxillary nerve blocks when performed by inexperienced anesthetists11 and that the
percutaneous approach is more difficult to perform because of its anatomic location.10
Modifying an infraorbital approach to the maxillary nerve, similar to the procedure
performed in canine cadavers,11 could offer an alternative, simple method for
approaching the maxillary nerve with a higher rate of success than for the traditional
percutaneous approach.
The trigeminal nerve and its branches provide innervation (motor, sensory, and
autonomic) to the face and nose and course through the pterygopalatine fossa. The
maxillary branch of the trigeminal nerve provides sensory innervation to the nose,
mucosa of the hard and soft palates, nasal vestibule, and choana via the pterygopalatine,
greater palatine, lesser palatine, and caudal nasal nerves, respectively.12,13 The ophthalmic
branch of the trigeminal nerve innervates most of the internal structures of the nose,
including the nasal turbinates, septum and lateral walls of the nasal cavity, and portions
of the nasal mucosa, and external structures of the eyes.14,15 The ophthalmic nerve of
dogs is in an anatomic location that is difficult and dangerous to approach; thus, a simple
approach that provides access to the maxillary nerve branches (which would partially
desensitize the nasal cavity) is necessary to provide antinociception for nasal procedures
such as rhinoscopy and biopsy.
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The objectives of the study reported here were to investigate the feasibility of a
modified infraorbital approach for a maxillary nerve block during a preliminary
experiment with canine cadavers then to conduct an in vivo study to assess the
effectiveness of the modified infraorbital approach for a maxillary nerve block in dogs
undergoing rhinoscopy and nasal biopsy. We hypothesized that dogs administered local
anesthetic in the pterygopalatine fossa via this maxillary nerve block technique would
have better anesthetic outcomes, decreased procedural nociception, and smoother
recovery (as indicated by better stability of vital parameters, decreased purposeful
movement, decreased plasma concentrations of stress biomarkers, and lower pain scores
during the recovery period), compared with results for a nonanesthetic control treatment.
Materials and Methods
Animals
Cadavers of 3 hound-type dogs were used in a preliminary experiment. Dogs were
euthanizeda for reasons unrelated to the present study at the conclusion of a teaching
laboratory.
Eight healthy adult (age range, 1 to 2 years) purpose-bred hound-type dogs were
used in an in vivo experiment. There were 4 spayed females, 3 sexually intact females,
and 1 sexually intact male. Mean ± SD body weight was 21.7 ± 2.1 kg. The dogs were
deemed healthy on the basis of results of physical examination, serum biochemical
analysis, and a heartworm test and evaluation of platelet count, prothrombin time,
activated partial thromboplastin time, PCV, and total solids concentrations. All dogs were
American Society of Anesthesiologists physical status class I. The study was approved by
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the Institutional Animal Care and Use Committee at the Mississippi State University
College of Veterinary Medicine.
Cadaver experiment
An infraorbital approach to the maxillary nerve described in another study11 was
replicated in each canine cadaver. A slight modification in the procedure (adjustment of
the distance the catheter was inserted through the infraorbital canal into the
pterygopalatine fossa) was performed to determine the best method for a maxillary nerve
block via the modified infraorbital approach to maximize delivery of local anesthetic to
the maxillary nerve and its branches within the pterygopalatine fossa. A 1% solution of
methylene blue stainb was injected into the pterygopalatine fossa; volume of injectate was
1, 1.5, and 3 mL as determined on the basis of published regional techniques that
involved the use of 0.5% bupivacaine.16 The stained and contralateral unstained
pterygopalatine fossa were carefully dissected, and tissues were evaluated to detect
trauma to the nerves or surrounding tissues as well as the degree of staining for each of
the nerves.
In vivo experiment
Experimental design
A blinded, placebo-controlled, crossover study was performed. Each dog was
randomly assigned (by a veterinary anesthesia technician who chose every other dog
from a list) to receive 0.5% bupivacaine (0.5%, 0.1 mL/kg) or an equivalent volume of
saline (0.9% NaCl) solution as a maxillary nerve block via the modified infraorbital
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approach. After a 14-day washout period, each dog received the alternate treatment on
the contralateral side.
The number of dogs in the study was determined by use of a power analysis. It
was assumed 4 dogs would be randomly assigned to receive the bupivacaine treatment
and the saline solution treatment in a crossover design whereby differences in mean
changes from baseline values for the various outcomes would be assessed with a paired t
test. Estimates of the variation anticipated for bupivacaine and saline solution treatments
were based on published values for a similar study10 that was conducted to compare
responses of dogs with maxillary nerve blocks to those of control dogs. The SDs reported
in that study10 for control dogs for changes in heart rate (6 beats/min) and MAP (5 mm
Hg) and for dogs with maxillary nerve blocks for changes in heart rate (6 beats/min) and
MAP (4 mm Hg) were used in the power calculations for the study reported here. For  =
0.05, correlation between paired measures within a dog = 0.5, and a 1-tailed test, those
SDs were used to estimate power of the study by use of available software.17,c The 8 pairs
of samples would allow detection of a difference in heart rate of 6 beats/min (power,
0.82) and a difference in the change in MAP of 4.5 mm Hg (power, 0.80).
Anesthesia
Food, but not water, was withheld for 12 hours before induction of anesthesia.
Dogs were premedicated with acepromazine maleated (0.01 mg/kg, IM) and
hydromorphonee (0.1 mg/kg, IM). Twenty minutes after administration of the
premedication, an 18-gauge, 5-cm catheterf was placed in a cephalic vein. Anesthesia was
induced with propofolg (2 to 4 mg/kg, IV, to effect), dogs were endotracheally intubated,
and anesthesia was maintained with isofluraneh (calibrated vaporizeri setting of 1.5 vol%)
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in oxygen (1.5 L/min) by use of a partial rebreathing circuit to achieve a surgical plane of
anesthesia, as evaluated by jaw tone, palpebral reflex, and eye position. Dogs were
mechanically ventilatedj to maintain end-tidal partial pressure of CO2 of 35 to 45 mm Hg.
Vital parameters were monitored by use of a multiparametric monitork and gas analyzer.l
Oscillometric blood pressures were monitored by use of an appropriately sized cuff on a
forelimb. A 20-gauge, 3.2-cm catheterf was placed in a dorsal pedal artery or an 18gauge, 5-cm catheterf was placed in a lateral saphenous vein; catheters were used for
collection of blood samples that were assayed to determine plasma cortisol and
norepinephrine concentrations. A forced-air warming devicem was used to maintain body
temperature between 37.2° and 38.3°C. Lactated Ringer’s solutionn was administered (5
mL/kg/h, IV). Heart rate, SAP, MAP, and DAP were manually recorded by the same 2
investigators (KMF and L-HK) every 5 minutes during anesthesia as well as before the
start of rhinoscopy (baseline), at the time of retroflexion of the endoscope in the caudal
portion of the nasopharynx, at the time of nasal biopsy, 5 minutes after biopsy, and 10
minutes after biopsy. Atropineo (0.02 mg/kg, IV) was administered as needed to resolve
substantial bradycardia associated with hypotension (MAP < 60 mm Hg). Dogs that had
purposeful movement (paddling, head shaking, chewing, or licking) that interfered with
procedures received additional propofol (0.5 mg/kg, IV).
Maxillary nerve block via a modified infraorbital approach
The location of the infraorbital canal was determined as a small indentation dorsal
to the third premolar that was palpable through the oral mucosa. A 20-gauge, 5-cm overthe-needle catheterf was placed in the infraorbital canal parallel to the maxilla and
directed caudally (Figure 2.1). The catheter was inserted to a depth of 5 mm, after which
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the cannula was withdrawn until the end was just within the tip of the catheter. The
catheter and cannula then were advanced until the hub of the catheter touched the gingiva
or resistance was encountered, whichever came first. Once the catheter was securely
within the infraorbital canal, the cannula was removed. Either 0.5% bupivacainee (0.5
mg/kg [0.1 mL/kg]) or an equivalent volume of saline solutionp was placed in a 3-mLsyringeq and injected into the infraorbital canals. The syringe was attached to the catheter,
aspiration was performed, and if no blood was aspirated, the solution was slowly injected.
If there was resistance to injection, the catheter was repositioned 2 to 3 mm to ensure it
was not within the perineurium or another vital structure,18,19 aspiration was performed,
and if no blood was aspirated, the volume was slowly injected. All regional nerve blocks
were performed by the same investigator (KMF).
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Figure 2.1

Maxillary nerve block technique

Photograph of a canine cadaver that illustrates a modified infraorbital approach for a maxillary
nerve block. The location of the infraorbital canal was determined as a small indentation dorsal to
the third premolar that was palpable through the oral mucosa. A 20-gauge, 5-cm over-the-needle
catheter was placed in the infraorbital canal parallel to the maxilla and directed caudally. The
catheter was inserted to a depth of 5 mm, after which the cannula was withdrawn until the end
was just within the tip of the catheter. The catheter and cannula then were advanced until the hub
of the catheter touched the gingiva or resistance was encountered, whichever came first.

Rhinoscopy and biopsy
Dogs were allowed to remain undisturbed in sternal recumbency for 30 minutes
after the maxillary nerve block to enable the local anesthetic to take effect.20 Standard
rhinoscopy with nasal mucosal biopsy then was performed on the left side of the nose. An
initial evaluation of the caudal portion of the nasopharynx was performed by retroflexion
with a standard pediatric gastroscope.r Direct examination of the nasal mucosa and
turbinates then was performed by use of a rigid endoscopes passed through the rostral
aspect of the nares. A single pinch biopsy specimen of tissues of the nasal cavity was
blindly obtained from the left side of the nose by use of an 8-mm biopsy instrument,t
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placed in neutral-buffered 10% formalin,u and submitted for histologic examination. All
rhinoscopy and biopsy procedures were performed by the same investigator (TMA).
Dogs remained anesthetized until postbiopsy blood samples were obtained and bleeding
from the biopsy site was controlled. After each dog had a 14-day washout period, the
procedures were repeated on the right side of the nose but with injection of the alternate
treatment solution for the maxillary nerve block.
Anesthetic recovery and postoperative pain scores
All dogs recovered from anesthesia in the intensive care unit. Vital parameters
(heart rate, respiratory rate, and rectal temperature) were monitored until dogs were
extubated and able to maintain sternal recumbency. Postoperative pain scores were
obtained by use of the Glasgow Composite Pain Scale–Short Form21 (scale, 0 to 24), a
VASv with a 10-cm scale, and the Colorado State University Canine Acute Pain Scale22
(scale, 0 to 4). Pain scores and vital parameters were recorded after extubation and 1, 2,
3, and 4 hours thereafter. Hydromorphonee (0.1 mg/kg, IV) was used for postoperative
rescue analgesia if dogs had a score > 6 of 20 or 8 of 24 for the Glasgow Composite Pain
Scale–Short Form, ≥ 3 cm for the VAS, or ≥ 3 for the Colorado State University Canine
Acute Pain Scale. All postoperative pain scores were assigned by 2 investigators (KMF
or BET).
Collection of blood samples
A blood sample (3 mL) was collected before the start of rhinoscopy (baseline), at
the time of retroflexion of the endoscope in the caudal portion of the nasopharynx, at the
time of biopsy, 5 minutes after biopsy, and 10 minutes after biopsy. Blood samples (10
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arterial and 6 venous) were placed in EDTA blood collection tubes.w Plasma was
harvested, and 500 L of plasma was mixed with 25 L of 70% perchloric acidx and
frozen at –80°C until analyzed to determine cortisol and norepinephrine concentrations.
Cortisol analysis
Frozen plasma samples were allowed to thaw at room temperature (20°C).
Atrazine mercapturatex was added as an internal standard (final concentration, 1M).
Samples were mixed on a vortex device, placed on ice, and then centrifuged (1,300 X g at
4°C for 15 minutes) to remove protein precipitate. Supernatant was transferred to highperformance liquid chromatography vials. Samples were analyzed for cortisol by use of
liquid chromatography–mass spectrometryy,z as described elsewhere.23 A stock solution
of cortisol (5M) was prepared in methanolx and used to create calibration standards in
PBS solution. Concentration of calibration standards ranged from 0.1nM to 100nM. New
calibration standards were prepared for each set of unknown samples. Each calibration
curve yielded comparable results (r2 > 0.990). The limit of quantification for cortisol was
estimated as 0.25nM.23
Norepinephrine analysis
Frozen plasma samples were allowed to thaw at room temperature (20°C). A 1M
tris solution containing 25 ng of 3,4-dihydroxybenzylaminex was added as an internal
control. Samples were centrifuged (1,300 X g at 4°C for 20 minutes) and then
centrifugation was repeated without disruption of the pellet. The supernatant was
transferred to microtubes containing 5 g of aluminum oxidex and 500 L of the tris–3,4dihydroxybenzylamine solution. Samples were shaken for 30 minutes and then
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centrifuged (1,300 X g for 30 seconds), and the supernatant was discarded. The pellet
was washed with 500 L of reverse-osmosis water and then centrifuged (1,300 X g for 30
seconds), and the supernatant was discarded. Washing was repeated, after which the
pellet was retrieved and 200 L of 100mM citric acidx was added. The sample was
shaken for 15 minutes and then centrifuged (1,300 X g for 30 seconds), and the
supernatant was harvested and analyzed. Supernatants were injected into a highperformance liquid chromatography system with an electrochemical detectoraa–cc by use
of a mobile phase of 100mM phosphate,x 17.5% methanol,x 25M EDTA,x and 1mM
octyl sodium sulfatex (pH, 3.65). The quantity of each compound was determined by
comparison with known concentrations in standards of norepinephrine.x Concentration of
calibration standards ranged from 0.1 to 100 ng. New calibration standards were prepared
for each set of unknown samples. Each calibration curve yielded comparable results (r2 >
0.990). The limit of quantification was not evaluated because all data points were within
limits of the calibration standard curve.
Histologic examination of nasal biopsy specimens
Formalin-fixed nasal biopsy specimens were routinely processed, embedded in
paraffin, and sectioned at a thickness of 5 m. Slides were stained with H&E stain for
evaluation. All histologic changes were evaluated by the same investigator (AKO). The
degree of lymphoplasmacytic inflammation was scored on a scale of 0 to 3 as follows: 0
= no inflammation, 1 = mild inflammation, 2 = moderate inflammation, and 3 = severe
inflammation. At least four 20X fields were evaluated for each specimen.
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Statistical analysis
Separate linear mixed modelsdd were fit for heart rate, SAP, MAP, DAP, plasma
cortisol concentration, plasma norepinephrine concentration, and the Glasgow Composite
Pain Scale–Short Form score. First or second anesthetic event (run), order of treatment
(sequence), treatment, time point, histologic score, treatment-by-time point interaction,
and treatment-by-histologic score interaction were included as fixed effects with a
Kenward-Rogers degrees of freedom method. Baseline measurement was also included in
the model as a covariate to adjust for variation in the result among dogs prior to the start
of rhinoscopy; consequently, time point included retroflexion, biopsy, 5 minutes after
biopsy, and 10 minutes after biopsy. Dog was included as random effect with a variance
component covariance structure. Repeated measures of dog within run for the various
time points were specified in a repeated statement with an autoregressive 1-covariance
structure. When sequence or run were not significant, they were sequentially removed
from the model. Treatment-by-histologic score interaction, histologic score, or treatmentby-time point interaction were also removed when they were not significant. Treatment
and time point were the variables of greatest interest and remained in the model
regardless of significance. Differences in least square means were determined for
outcomes with significant effects. The P values were adjusted to account for multiple
comparisons by use of a simulation option,ee which was used to estimate the critical value
while incorporating the correlation structure of the model and can be an effective method
for multiple comparisons for mixed models.24 In the case of a significant effect for the
treatment-by-time point interaction, differences in least square means between treatments
were determined at each time point and among time points within each treatment by use
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of estimation statementff with a simulation adjustment for multiple comparisons.
Distribution of the conditional residuals was evaluated for each outcome to ensure
assumptions of the statistical model had been met.
Purposeful movement and Colorado State University Canine Acute Pain Scale
scores were dichotomized (absent or present); VAS also was dichotomized (absent was ≤
1 cm and present was > 1 cm). After dichotomization was performed, logistic regression
by use of a separate generalized linear mixed modelgg was fit for purposeful movement,
Colorado State University Canine Acute Pain Scale scores, and VAS. Run, sequence,
histologic score, and treatment were included as fixed effects. Dog was included as a
random effect with a variance component covariance structure. When sequence or run
were not significant, they were sequentially removed from the model. Histologic score
was also removed if not significant. Values of P < 0.05 were considered significant. All
data are described as mean ± SEM.
Statistical analysis of histologic results were evaluated by use of the MannWhitney U test. One dog was excluded from the histologic analysis because it was
considered an outlier that would have skewed the results. Values of P < 0.05 were
considered significant.
Results
Cadaver experiment
Results of the cadaver experiment indicated that for use of a modified infraorbital
approach to the maxillary nerve block, 3 mL of methylene blue was required to stain all
branches of the maxillary nerve within the pterygopalatine fossa, including the
zygomatic, pterygopalatine, greater palatine, lesser palatine, caudal nasal, infraorbital,
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and superior alveolar nerves (Figure 2.2). Smaller volumes did not penetrate all of the
nerves. A volume of 3 mL was equivalent to 0.5 mg of 0.5% bupivacaine/kg (0.1 mL/kg)
injected into each pterygopalatine fossa. Gross trauma to the nerves or surrounding
structures within the infraorbital canal or pterygopalatine fossa was not detected. All
nerves had > 6 mm of staining, which indicated that a complete nerve block would have
resulted from the use of a 3-mL volume of local anesthetic25–27; thus approximately 3 mL
of injectate was used for the in vivo experiment (adjusted to a volume of 0.1 mL/kg for
each nerve block).

Figure 2.2

Nerve staining

Photograph of structures in the right pterygopalatine fossa following injection of 3 mL of
methylene blue via a 20-gauge, 5-cm catheter placed into the pterygopalatine fossa
through the infraorbital canal by use of a modified infraorbital approach for a maxillary
nerve block. There is complete staining of the maxillary nerve and its branches. Notice
the maxillary nerve (m), infraorbital nerve (i), greater palatine nerve (g), pterygopalatine
nerve (p), caudal nasal nerve (c), lesser palatine nerve (l), and tip of the catheter (t).
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In vivo experiment
Fixed effects of sequence, run, histologic score, treatment-by-histologic score
interaction, and treatment-by-time point interaction were not significant and removed
from the models for SAP, MAP, DAP, heart rate, and norepinephrine concentration;
treatment and time point remained in the models as fixed effects regardless of
significance. The baseline value for each outcome was included in the models regardless
of significance to act as a covariate to control for differences in baselines values among
dogs.
Compared with results for saline solution, bupivacaine had a significant effect on
blood pressures when model was adjusted across all time points from retroflexion to 10
minutes after biopsy for baseline values (Figure 2.3). Bupivacaine and saline solution
differed significantly with regard to mean ± SEM for SAP (103 ± 2 mm Hg and 117 ± 3
mm Hg, respectively [P = 0.005]), MAP (74 ± 2 mm Hg and 93 ± 4 mm Hg, respectively
[P = 0.019]), and DAP (59 ± 2 mm Hg and 81 ± 4 mm Hg, respectively [P = 0.024]).
There was no significant effect of time point on SAP (P = 0.864), MAP (P = 0.542), or
DAP (P = 0.788). Baseline values for each outcome were significant (all P < 0.014) in
their respective models, which indicated there was variation among dogs prior to the start
of rhinoscopy for each outcome. Including the baseline values in the model accounted for
this source of variation.
Treatment did not have a significant (P = 0.056) effect on heart rate; however,
there was a significant (P < 0.001) effect of time point on heart rate, when adjusted for
the effect of treatment and baseline values (Figure 3). Mean ± SEM heart rate was
significantly higher at biopsy (94 ± 5 beats/min) than at retroflexion (81 ± 5 beats/min [P
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< 0.001]), 5 minutes after biopsy (84 ± 4 beats/min [P < 0.001]), and 10 minutes after
biopsy (84 ± 4 beats/min [P = 0.013]). Three dogs (1 saline solution and 3 bupivacaine)
received atropine, though there were no significant differences in heart rate between the
dogs receiving atropine and untreated dogs. Significant (P < 0.001) variation in baseline
heart rate among the dogs before the start of rhinoscopy was accounted for by inclusion
in the model.
The treatment-by-time point interaction had a significant (P = 0.038) effect on
plasma cortisol concentration (Figure 2.4). Mean ± SEM plasma cortisol concentration
increased significantly (P = 0.006) from biopsy (8.3 ± 1.6nM) to 5 minutes after biopsy
(17.8 ± 4.7nM) for the saline solution treatment. There was a similar, but not significant
(P = 0.055), increase between biopsy and 10 minutes after biopsy (17.8 ± 5.4nM) for the
saline solution treatment. No other significant differences were detected among time
points within the saline solution treatment (all P > 0.157), among time points within the
bupivacaine treatment (all P > 0.997), or between bupivacaine and saline solution at any
time point (all P > 0.212). Plasma norepinephrine concentrations did not differ
significantly between bupivacaine and saline solution (P = 0.212) or among time points
(P = 0.783).
In regard to clinical evaluation of dogs during rhinoscopy and nasal biopsy, 4 of 8
dogs had purposeful movement at least once during the procedure when injected with
saline solution, whereas only 2 of 8 dogs had purposeful movement when injected with
bupivacaine, but these proportions did not differ significantly (P = 1.00). The Glasgow
Composite Pain Scale–Short Form scores for all dogs ranged from 0 to 11; there was no
significant (P = 0.24) difference between scores for the saline solution and bupivacaine
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treatments. Seven of 8 dogs had a score ≥ 1 (range, 0 to 2) for the Colorado State
University Canine Acute Pain Scale when receiving saline solution, whereas 5 of 8 dogs
had a score ≥ 1 (range, 0 to 2) when receiving bupivacaine; these proportions did not
differ significantly (P = 0.264). Three of 8 dogs had a VAS score > 1 cm (range, 0 to 5
cm) when receiving saline solution, whereas 1 of 8 dogs had a VAS score > 1 cm (range,
0 to 5 cm); these proportions did not differ significantly (P = 0.264). One dog required
postoperative analgesia immediately after extubation when receiving bupivacaine
(Glasgow Composite Pain Scale–Short Form score, 11/24; VAS score, 5 cm). No other
dogs in the study required postoperative analgesia.
Histologic examination of the nasal biopsy specimens revealed that all dogs had
mild to severe lymphoplasmacytic inflammation in the lamina propria. Six dogs had the
same inflammation score on both sides, 1 dog had a higher score for the side when saline
solution was administered, and 1 dog had a chondrosarcoma for the side when saline
solution was administered. There was not a significant (P = 0.65) difference in the degree
of inflammation between the 2 treatments.
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Blood pressure and heart rate

Mean ± SEM values for SAP (A), MAP (B), DAP (C), and heart rate (D) for 8 dogs that
underwent rhinoscopy and nasal biopsy after receiving a maxillary nerve block via a
modified infraorbital approach with 0.5% bupivacaine (gray bars) and an equivalent
volume of saline (0.9% NaCl) solution (white bars). There was a 14-day washout period
between treatments. Blood samples and recording of blood pressure and heart rate were
performed immediately before start of rhinoscopy (Baseline), at the time of retroflexion
of the endoscope in the caudal portion of the nasopharynx (Retro), at the time of nasal
biopsy (NB), 5 minutes after nasal biopsy (NB + 5), and 10 minutes after nasal biopsy
(NB + 10).
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Figure 2.4

Cortisol and norepinephrine concentrations

Mean ± SEM values for plasma concentrations of cortisol (A) and norepinephrine (B) for
8 dogs that underwent rhinoscopy and nasal biopsy after receiving a maxillary nerve
block via a modified infraorbital approach with 0.5% bupivacaine (gray bars) and an
equivalent volume of saline (0.9% NaCl) solution (white bars). See Figure 3 for
remainder of key.
Discussion
Use of the infraorbital canal to approach the maxillary nerve in the
pterygopalatine fossa for administration of local anesthetic in healthy dogs undergoing
rhinoscopy and nasal biopsy was associated with relatively limited changes, compared
with results after the administration of saline solution. Significant differences between
bupivacaine and saline solution were detected for several variables, including SAP, MAP,
and DAP, when controlling for time point and baseline values in the model. Significant
changes in plasma cortisol concentrations were detected when comparing biopsy versus 5
minutes after biopsy within the saline solution treatment. Similar, but not significant,
changes were seen between biopsy versus 10 minutes after biopsy within the saline
solution treatment. There was no significant difference between the treatments for heart
rate, plasma norepinephrine concentration, purposeful movement, or postoperative pain
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scores. There also was no subjective clinical difference between treatments during the
anesthetic or recovery periods.
On the basis of the results of the present cadaver experiment and another cadaver
study,11 a maxillary nerve block via a modified infraorbital approach would be expected
to block sensory transmission to all nerves within the pterygopalatine region that provide
sensory innervation to structures of the nose and face. However, given the anatomy of
these nerves in mesaticephalic dogs, a modified infraorbital approach to the maxillary
nerve block cannot completely block sensation within the nasal cavity. Branches of
nerves that travel through the nasal cavity are not in close proximity to the local
anesthetic injected into the pterygopalatine fossa and are not subject to the effects of the
local anesthetic. The ethmoidal nerve, a branch of the ophthalmic nerve that innervates
portions of the nasal mucosa and turbinates,13,14 courses along the orbital cone and not
through the pterygopalatine fossa; therefore, it most likely cannot be blocked by use of a
modified infraorbital approach. To block the ethmoidal nerve and provide desensitization
to the nasal mucosa and turbinates, a different nerve block approach would be required,
which was not investigated in the present study. The zygomatic nerve, a branch of the
maxillary nerve that innervates portions of the tissue surrounding the eyes, could be
blocked via a modified infraorbital approach, which would cause temporary
desensitization to the superficial structures of the eyes and orbital cone but would not
provide innervation to structures within the nasal cavity.14
In a recent study,28 a transorbital approach to the maxillary nerve was evaluated
and compared with a traditional percutaneous approach to the maxillary nerve. This
transorbital approach, which is much more similar to maxillary nerve blocks performed
43

in humans, can also be difficult for inexperienced anesthetists and can be associated with
additional complications. A modified infraorbital approach to the maxillary nerve can be
performed by inexperienced anesthetists, without concerns about globe rupture, maxillary
artery puncture, or oculocardiac reflex. Both approaches, with the addition of a modified
infraorbital approach to the maxillary nerve block, can provide desensitization to portions
of the nasal cavity, although a modified infraorbital approach may be easier for
inexperienced anesthetists.
In humans, maxillary nerve blocks are used for facial and nasal procedures in
sedated and anesthetized patients, to help minimize anesthetic complications, and to
decrease postoperative pain. The maxillary nerve and its branches are easily approached
in many nerve block methods in humans. Many of these nerve block methods are similar
to those performed in dogs, but the anatomic orientation of the human nose and face
differ from those of dogs. The close proximity of the maxillary and ophthalmic branches
to each other in humans allows for local anesthetic to travel between these nerves, likely
partially blocking the ophthalmic nerve when a maxillary or infraorbital nerve block is
performed. Studies29–32 in pediatric human patients have revealed a decreased opioid
requirement and improved postoperative pain when comparing maxillary blocks with a
placebo, and similar results have been seen in adult patients undergoing nasal procedures
who received infraorbital nerve blocks.33–36 In these same studies,33-36 1 to 3 mL of local
anesthetic was administered to adults and 0.15 mL/kg was administered to pediatric
patients, which are volumes comparable to those used in dogs in the study reported here.
In the present study, a modified infraorbital approach to the maxillary nerve block was
only tested in mesaticephalic hound-type dogs. Use of this nerve block technique in
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brachycephalic dogs or in other species (eg, cats) with shorter trigeminal nerve branches
has the potential to provide better antinociception. In those animals, a shorter distance for
diffusion of the local anesthetic along the maxillary nerve to reach the ophthalmic nerve
as well as a larger volume of local anesthetic relative to nerve length may result in a more
complete blockade of the nasal mucosa and turbinates.
Blood pressures (SAP, MAP, and DAP) differed significantly between the
treatments, with blood pressures generally higher during the study period for the saline
solution treatment. Although heart rate increased more for the saline solution treatment
than the bupivacaine treatment, this change was not significantly different between
treatments. Blood pressures and heart rates typically were higher for the saline solution
treatment than the bupivacaine treatment, which led us to suspect that dogs receiving the
saline solution treatment had a greater nociceptive stimulus.37 Some dogs (1 saline
solution and 2 bupivacaine) were treated with atropine to resolve bradycardia associated
with hypotension, which likely played a role in the blood pressure and heart rate changes,
although atropine was administered prior to the start of the rhinoscopy and nasal biopsy
procedures and before blood samples were collected or variables were recorded.
Cortisol and norepinephrine are biomarkers of stress and can be indicators of pain
in humans and other animals.38–40 Measurement of these biomarkers can be used to
indicate stress responses attributable to nociception during anesthetic procedures,37,38,41
postoperative pain,42 trauma,43 medication administration,40,44 and behavioral
stresses.39,45–47 Norepinephrine is produced as an immediate response to stress,39 whereas
cortisol can take up to 4 to 6 hours to reach peak concentrations following surgical
trauma.43 However, changes in plasma norepinephrine concentrations were more
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prolonged than changes in plasma cortisol concentrations in some studies.37,44 The
magnitude of change of plasma norepinephrine concentration following a nociceptive
stimulus has been reported as being much smaller than that of the plasma cortisol
concentration.40 Variability in biomarker changes in response to a stimulus can make it
difficult to interpret changes in plasma norepinephrine concentrations. In the present
study, plasma cortisol and norepinephrine concentrations were measured before, during,
and after rhinoscopy and nasal biopsy, and we found that plasma cortisol concentrations
in dogs receiving saline solution increased significantly from biopsy to 5 minutes after
biopsy, which suggested that the local anesthetic blocked nociceptive stimulation of the
nasal cavity to some degree.48 In contrast, no significant changes were seen in plasma
norepinephrine concentrations at any of the measured time points. A longer
postprocedure time period for measurement of plasma cortisol and norepinephrine
concentrations may have provided more information regarding nociception, and stress in
these dogs.
The dogs used in the present study were a subjectively normal, healthy group that
consisted of a sexually intact male and both sexually intact and spayed females. Sex and
reproductive status did not factor into results for the study reported here because each dog
served as its own control animal. Although including only dogs of the same sex and
reproductive status would have provided a more uniform study population, this was not a
viable option because of the dogs available for use at the time of the study.
On the basis of histologic examination of the nasal biopsy specimens,
lymphoplasmacytic inflammation was seen in some dogs, but there was no difference
between the 2 treatments with regard to severity of inflammation. An incidental
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chondrosarcoma was found on 1 side of 1 dog receiving saline solution. No clinical
evidence of disease was noted prior to obtaining biopsy specimens in any of the dogs in
this study.
A modified infraorbital approach to the maxillary nerve block in the present study
did not clearly reduce the degree of purposeful movement seen clinically during
rhinoscopy and nasal biopsy, compared with results for the saline solution treatment. No
subjective differences were seen during recovery between dogs when receiving saline
solution or bupivacaine because pain scores were not significantly different between
treatments at any time point. All pain scores were assigned by 2 investigators who were
well versed on pain scoring rubrics prior to the start of the present study. One limitation
of the study, especially for postoperative pain scoring, was that the subjects were
relatively poorly socialized research dogs that had unpredictable behavior when placed in
a cage within the intensive care facility and that were not conditioned to touching of their
head and face.46,47 Therefore, a portion of the similarities and differences in pain scores
between dogs for the 2 treatments could have been based on behavior and not necessarily
on pain. A future study in client-owned animals that are better conditioned to human
interaction may change the outcome for postoperative pain scoring, which would
potentially allow for behavioral changes attributable to pain to be differentiated from
changes attributable to anxiety in a stressful environment.
Results of a power analysis performed before the start of the present study
suggested that significant changes in heart rate and blood pressure would be detected
when a small sample size (n = 16) was used. Had the study population been larger,
additional significant differences, especially in heart rate, plasma norepinephrine
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concentration, and pain score, may have been detected. Both cost and dog availability
prohibited a larger study population, although a larger clinical study involving clientowned animals with clinically relevant nasal disease may provide additional significant
findings.
On the basis of findings for the present study, there is evidence, including blood
pressures and plasma cortisol concentration, that use of a modified infraorbital approach
for a maxillary nerve block could decrease nociceptive and stress responses in dogs
undergoing rhinoscopy and nasal biopsy. However, clinical implications for performing a
maxillary nerve block via a modified infraorbital approach are not yet clear. There were
no observed differences in purposeful movement, postoperative pain scores, or anesthetic
recovery; thus, results of the present study suggested that the use of this nerve block
technique may not cause any clinical differences in overt indicators of nociceptive
responses in dogs. This nerve block technique was not studied in a variety of breeds of
dog or in other species and was only investigated in healthy dogs that did not have
outward clinical signs of nasal disease. A weakness of the study was that we did not test
the modified infraorbital approach for a maxillary nerve block for efficacy in dogs
without subsequent rhinoscopy and nasal biopsy, which could have ensured that the nerve
block was able to block the appropriate nerves. It was possible that all dogs receiving
bupivacaine did not have the same amount of pain control with the block. In patients with
clinically relevant nasal disease, a modified infraorbital approach for a maxillary nerve
block may cause different outcomes. In dogs that are not healthy, particularly those with
systemic disease, dose-dependent cardiorespiratory effects of anesthetics are likely to be
more profound, and this nerve block may help minimize these anesthetic complications in
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dogs for which rhinoscopy and nasal biopsy are clinically indicated. Care should be used
when performing this maxillary nerve block in dogs with a space-occupying lesion that
spreads beyond the nasal cavity because potential seeding of tumor cells could result.49,50
In the study reported here, maxillary nerve block via a modified infraorbital
approach resulted in evidence of decreased nociception, as determined on the basis of
blood pressures and plasma cortisol concentrations associated with rhinoscopy and nasal
biopsy; therefore, this maxillary nerve block technique could help reduce
cardiorespiratory effects of inhalation anesthetics during nasal procedures. However, the
lack of clinical differences in purposeful movements during nasal procedures and in pain
scores during the recovery period suggested that this maxillary nerve block technique
may not be effective in decreasing nociception during procedures and pain during the
recovery period. Further investigation of a modified infraorbital approach for a maxillary
nerve block in animals with clinically relevant nasal disease undergoing rhinoscopy and
nasal biopsy are indicated.
Footnotes
a.

VetOne Euthanasia, MWI, Boise, Idaho

b.

Methylene blue 1%, Akorn Inc, Lake Forest, Ill.

c.

G*Power 3.1.9.22, Heinrich-Heine-Universität, Düsseldorf, Germany,
http://www.gpower.hhu.de/en.html.

d.

Henry Schein Animal Health, Dublin, Ohio.

e.

Hospira Animal Health, Lake Forest, Ill.

f.

Surflo IV catheters, Terumo Medical Corp, Elkton, Md.

g.

Abbott Laboratories, North Chicago, Ill.
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h.

Piramal Healthcare, Bethlehem, Pa.

i.

Isotec vaporizer, Smiths Medical PM Inc, Norwell, Mass.

j.

Hallowell ventilator, model 2002, Hallowell EMC, Pittsfield, Mass.

k.

Vetrends V, Systemvet, Tampa, Fla.

l.

Poet gas analyzer, Criticare Systems Inc, Waukesha, Wis.

m.

3M Bair Hugger, Arizant Inc, Eden Prairie, Minn.

n.

Baxter Healthcare Corp, Deerfield, Ill.

o.

MWI, Boise, Idaho.

p.

B. Braun Medical Inc, Irvine, Calif.

q.

Terumo syringe, Terumo Medical Corporation, Somerset, NJ.

r.

Olympus GIF-XP160, Olympus America, Center Valley, Pa.

s.

Storz E013, Karl Storz Endoscopy-America Inc, El Segundo, Calif.

t.

Eppendorfer 9-inch biopsy forceps, MPM Medical Supply, Freehold, NJ.

u.

Vedco Inc, St Joseph, Mo.

v.

Visual Scales LLC, Encino, Calif.

w.

Tyco Healthcare Group LP, Mansfield, Mass.

x.

Sigma Aldrich, St Louis, Mo.

y.

Thermo quantum access max, Thermo Fisher Scientific, San Jose, Calif.

z.

Thermo Excaliber 2.0 software, Thermo Fisher Scientific, San Jose, Calif.

aa.

Waters 2695 separation module, Waters Corp, Milford, Mass.

bb.

SupleCosil LC-18-DB column, Waters Corp, Milford, Mass.

cc.

Waters 2465 electrochemical detector, Waters Corp, Milford, Mass.

dd.

PROC MIXED, SAS for Windows, version 9.4, SAS Institute Inc, Cary, NC.
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ee.

LSMEANS, SAS for Windows, version 9.4, SAS Institute Inc, Cary, NC.

ff.

LSMESTIMATE, SAS for Windows, version 9.4, SAS Institute Inc, Cary, NC.

gg.

PROC GLIMMIX, SAS for Windows, version 9.4, SAS Institute Inc, Cary, NC.
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CONCLUSION
Use of the modified infraorbital approach to the maxillary nerve in canine patients
has been shown to have some effect in anesthetizing the structures of the nasal cavity in
healthy dogs undergoing rhinoscopy with nasal biopsy. When comparing the dogs
receiving bupivacaine to the dogs receiving saline, there was a significant decrease in
blood pressures and plasma cortisol concentrations in the dogs receiving bupivacaine
blocks. A complete nerve block of the nasal cavity was not achieved, though it appears
that a partial nerve block was achieved, providing some benefit by decreasing
nociception during the rhinoscopy and nasal biopsy procedure, as evidenced by a lower
blood pressure and plasma cortisol concentration. Clinically, however, there did not
appear to be any objective difference between the dogs receiving the block and dogs that
did not, especially during the recovery period.
Pain score results were similar between the different treatments, though our
evaluation and scoring methods may have been misleading. Our goal was to utilize three
different pain scoring rubrics to help identify any differences in pain between the
bupivacaine and saline treated dogs during the post-operative period, though that was not
evident in this study. All of the dogs received similar pain scores, with only one dog in
the bupivacaine treatment scoring high enough to warrant rescue analgesia. It was very
difficult to determine if this dog was truly painful or instead responding to human
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interaction and manipulation of the head and face. Being purpose-bred research dogs,
they were not preconditioned to having their faces palpated and wearing an Elizabethan
collar. During the recovery period, all of the dogs were hyper-responsive to anyone
touching or being near their face, likely masking a true pain response with underlying
anxiety. In this study, however, the response to manipulation of the face (response to
palpation and Elizabethan collar placement) was not evaluated prior to anesthesia,
making differentiating pain from stress and anxiety difficult. The dogs chosen for this
study were from a research colony and were not well socialized to human interaction, at
least to a level comparable to most companion dogs. Studies addressing behaviors in
laboratory beagles showed that dogs bred within the facility are better socialized than
dogs obtained from elsewhere, with striking differences in behavior and body language.1
Though these dogs were quite well behaved, they did not possess the characteristics
commonly seen in client-owned companion dogs, most notably behaviors associated with
normal, everyday, human interaction.
Continuing this study protocol with clinical client-owned dogs may provide
different results, especially with respect to pain scoring in the recovery period. With the
significant differences seen in blood pressures and plasma cortisol concentrations, there is
interest in the idea that dogs who are conditioned to human interaction, have been
rewarded for social behavior, and regularly visit the veterinary hospital, may show very
different pain scoring results than those seen by purpose-bred laboratory dogs. With
regard to the pain scoring methods, it has been very difficult to develop a pain scoring
system that is user friendly, does not have significant inter-observer differences, and can
be validated in our animal patients.2-4 Much like in human pediatric medicine, out
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patients are unable to voice that they are experiencing pain, but will do so with subtle
behavioral cues, with their level of training and social interaction affecting these cues.1,5
Differences in the anatomy of the dog nose, in comparison to that of the human
face, can help to account for why this nerve block is not completely effective in
anesthetizing all of the structures of the canine nose. Skull anatomy of the dog is
significantly different than that of the human and proves anesthetizing the nose a difficult
task. The orientation of the human skull is such that complete blockade of the trigeminal
nerve can be accomplished, though this is not routinely used for diagnostic procedures
and is reserved for use in severe pain disorders, such as trigeminal neuralgia.6,7 Blockade
of the trigeminal ganglion in the dog would be a risky procedure that could result in long
term side effects, and accomplishing this may not be possible in the dog.
Altering the injectate used for the nerve block, such as by changing the drug
combination or increasing the volume injected, may improve the benefit of this maxillary
nerve block. By increasing the volume of local anesthetic injected, either by increasing
the dose or diluting the same dose, a greater distance of spread of drug would occur and it
may be more likely that some local anesthetic would reach the trigeminal ganglion or
ophthalmic nerve. It also must be taken into account that local anesthetics are toxic at
high doses and concentration does alter their analgesic effects. The addition of different
drugs to the injectate, such as an opioid or α-2 agonist, may increase the duration of
effect of the maxillary block, though not necessarily increase its spread to more distant
nerves. Adjuncts are commonly used in conjunction with local anesthetics to improve
analgesia effect and duration.8
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Additional studies in clinically affected dogs may show more insight into the
benefit of multimodal anesthesia in patients with disease processes that may complicate
the effects of anesthesia. It is also difficult to presume, that in brachycephalic dogs and
cats with significant facial anatomy variability, and shorter distance for the maxillary
nerve to travel, that the modified infraorbital approach to the maxillary nerve can provide
better anesthesia to the structures within the nasal cavity. The distance the local
anesthetic needs to travel, as well as the volume of local anesthetic administered, may
account for the incomplete block of the nasal cavity. Additional studies testing the
differences between brachycephalic and mesaticephalic dog breeds, and cats, as well as
testing different local anesthetics volumes may give greater insight into the clinical usage
of this nerve block in veterinary patients undergoing rhinoscopy with nasal biopsy. The
decreased blood pressure and plasma cortisol concentrations seen while under anesthesia
gives us hope that testing this nerve block method in client owned animals, and in
animals with increased anesthetic complication risks, may result in the outcome initially
intended, with improvement in recovery scores and reduced anesthetic complications
associated with rhinoscopy with nasal biopsy. Our hope is that this nerve block method
can prove clinically beneficial, and a simple procedure for inexperienced anesthetists to
perform. Regional nerve blocks, especially new approaches to classic procedures, can be
very safe if performed correctly, and beneficial, providing long acting anesthesia and
analgesia for animals undergoing various diagnostic and surgical procedures.
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